headlinespreviousopinionsconnectfields
infoquestionsdashboardupdates

The Impact of AI Scribes on Healthcare Quality

December 6, 2024 - 02:43

The Impact of AI Scribes on Healthcare Quality

Sari Altschuler, a professor of English, raises concerns about the implications of employing AI scribes for medical note-taking. While the technology promises efficiency and time-saving benefits for healthcare professionals, Altschuler argues that it may inadvertently compromise the quality of patient care.

AI scribes are designed to automate the documentation process, allowing physicians to focus more on patient interaction. However, Altschuler points out that reliance on artificial intelligence for such critical tasks could lead to a decline in the depth and accuracy of medical records. The nuances of patient interactions might be lost in translation, resulting in a less personalized approach to healthcare.

Moreover, the professor emphasizes that the human element in medical documentation is irreplaceable. Physicians often rely on their instincts and understanding of patient history, which AI may not fully capture. As healthcare continues to evolve with technology, the balance between efficiency and quality remains a key concern for practitioners and patients alike.


MORE NEWS

The rise of Zyn-like pouches for sleep, health, focus, teeth

July 21, 2026 - 06:41

The rise of Zyn-like pouches for sleep, health, focus, teeth

The success of Zyn nicotine pouches has sparked a wave of copycat products that promise to deliver everything from better sleep to sharper focus, all through a small pouch tucked inside the lip....

FDA says it’s still investigating Taylor Farms in cyclosporiasis outbreak

July 20, 2026 - 19:14

FDA says it’s still investigating Taylor Farms in cyclosporiasis outbreak

The U.S. Food and Drug Administration has clarified that a false-positive lab result does not alter the `overwhelming epidemiological data` pointing to Taylor Farms as the source of a...

Seven peptides are under review by an FDA panel this week. Here’s everything we know

July 20, 2026 - 11:31

Seven peptides are under review by an FDA panel this week. Here’s everything we know

A federal advisory committee is set to meet this week to evaluate seven peptide products, a move that could reshape how these compounds are made and prescribed in the United States. The panel,...

Second death reported in Legionnaires’ disease outbreak in New York City

July 19, 2026 - 23:21

Second death reported in Legionnaires’ disease outbreak in New York City

Health officials in New York City have confirmed a second fatality linked to an ongoing outbreak of Legionnaires` disease. The city`s Department of Health and Mental Hygiene announced the death on...

read all news
suggestionsheadlinespreviousopinionsconnect

Copyright © 2026 Bioflox.com

Founded by: Angelo McGillivray

fieldsinfoquestionsdashboardupdates
privacycookie settingsterms of use